| Product Code: ETC7640356 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The small volume parenteral import shipments to Ireland saw significant growth in 2024, with top exporting countries being Germany, UK, USA, Canada, and other areas. The market concentration, as measured by the HHI, increased from moderate to high in 2024, indicating a more consolidated market. The impressive CAGR of 23.25% from 2020 to 2024 highlights the strong demand for small volume parenteral products in Ireland. Moreover, the remarkable growth rate of 68.68% from 2023 to 2024 suggests a rapid expansion of this market segment, signaling potential opportunities for stakeholders.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Ireland Small Volume Parenteral Market Overview |
3.1 Ireland Country Macro Economic Indicators |
3.2 Ireland Small Volume Parenteral Market Revenues & Volume, 2021 & 2031F |
3.3 Ireland Small Volume Parenteral Market - Industry Life Cycle |
3.4 Ireland Small Volume Parenteral Market - Porter's Five Forces |
3.5 Ireland Small Volume Parenteral Market Revenues & Volume Share, By Form, 2021 & 2031F |
3.6 Ireland Small Volume Parenteral Market Revenues & Volume Share, By Dose Type, 2021 & 2031F |
3.7 Ireland Small Volume Parenteral Market Revenues & Volume Share, By Packaging, 2021 & 2031F |
3.8 Ireland Small Volume Parenteral Market Revenues & Volume Share, By Indication, 2021 & 2031F |
4 Ireland Small Volume Parenteral Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of chronic diseases in Ireland leading to higher demand for small volume parenteral products |
4.2.2 Technological advancements in manufacturing processes leading to cost efficiency and improved product quality |
4.2.3 Growing geriatric population in Ireland requiring more healthcare services and treatments |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for manufacturing and distribution of small volume parenteral products |
4.3.2 Limited availability of skilled healthcare professionals leading to challenges in administering small volume parenteral products effectively |
4.3.3 Pricing pressures and reimbursement issues impacting the profitability of small volume parenteral products |
5 Ireland Small Volume Parenteral Market Trends |
6 Ireland Small Volume Parenteral Market, By Types |
6.1 Ireland Small Volume Parenteral Market, By Form |
6.1.1 Overview and Analysis |
6.1.2 Ireland Small Volume Parenteral Market Revenues & Volume, By Form, 2021- 2031F |
6.1.3 Ireland Small Volume Parenteral Market Revenues & Volume, By Liquid, 2021- 2031F |
6.1.4 Ireland Small Volume Parenteral Market Revenues & Volume, By Dry, 2021- 2031F |
6.2 Ireland Small Volume Parenteral Market, By Dose Type |
6.2.1 Overview and Analysis |
6.2.2 Ireland Small Volume Parenteral Market Revenues & Volume, By Single-dose, 2021- 2031F |
6.2.3 Ireland Small Volume Parenteral Market Revenues & Volume, By Multiple-dose, 2021- 2031F |
6.3 Ireland Small Volume Parenteral Market, By Packaging |
6.3.1 Overview and Analysis |
6.3.2 Ireland Small Volume Parenteral Market Revenues & Volume, By Ampoules, 2021- 2031F |
6.3.3 Ireland Small Volume Parenteral Market Revenues & Volume, By Vials, 2021- 2031F |
6.3.4 Ireland Small Volume Parenteral Market Revenues & Volume, By Pre-filled Syringes, 2021- 2031F |
6.3.5 Ireland Small Volume Parenteral Market Revenues & Volume, By Cartridges, 2021- 2031F |
6.3.6 Ireland Small Volume Parenteral Market Revenues & Volume, By Bottles, 2021- 2031F |
6.3.7 Ireland Small Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
6.4 Ireland Small Volume Parenteral Market, By Indication |
6.4.1 Overview and Analysis |
6.4.2 Ireland Small Volume Parenteral Market Revenues & Volume, By Pain Management, 2021- 2031F |
6.4.3 Ireland Small Volume Parenteral Market Revenues & Volume, By Cancer Care, 2021- 2031F |
6.4.4 Ireland Small Volume Parenteral Market Revenues & Volume, By Malnourishment, 2021- 2031F |
6.4.5 Ireland Small Volume Parenteral Market Revenues & Volume, By Diabetes, 2021- 2031F |
6.4.6 Ireland Small Volume Parenteral Market Revenues & Volume, By Others, 2021- 2031F |
7 Ireland Small Volume Parenteral Market Import-Export Trade Statistics |
7.1 Ireland Small Volume Parenteral Market Export to Major Countries |
7.2 Ireland Small Volume Parenteral Market Imports from Major Countries |
8 Ireland Small Volume Parenteral Market Key Performance Indicators |
8.1 Percentage increase in the adoption rate of small volume parenteral products by healthcare facilities in Ireland |
8.2 Number of new product developments and innovations in the small volume parenteral market |
8.3 Rate of compliance with regulatory standards for small volume parenteral product manufacturing and distribution |
8.4 Average time taken for healthcare professionals to administer small volume parenteral products accurately and safely |
8.5 Number of partnerships and collaborations between small volume parenteral manufacturers and healthcare facilities in Ireland |
9 Ireland Small Volume Parenteral Market - Opportunity Assessment |
9.1 Ireland Small Volume Parenteral Market Opportunity Assessment, By Form, 2021 & 2031F |
9.2 Ireland Small Volume Parenteral Market Opportunity Assessment, By Dose Type, 2021 & 2031F |
9.3 Ireland Small Volume Parenteral Market Opportunity Assessment, By Packaging, 2021 & 2031F |
9.4 Ireland Small Volume Parenteral Market Opportunity Assessment, By Indication, 2021 & 2031F |
10 Ireland Small Volume Parenteral Market - Competitive Landscape |
10.1 Ireland Small Volume Parenteral Market Revenue Share, By Companies, 2024 |
10.2 Ireland Small Volume Parenteral Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here